PFIZER

Kids ages 5 to 11 should get a booster dose of Pfizer’s COVID-19 vaccine, advisers to the U.S.[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]

It's not just among kids — infections are on the rise nationwide.

Less than a third of children ages 5 to 11 years old are fully vaccinated and will become eligible for the third shot.

If the Centers for Disease Control and Prevention agrees, as expected, it would open a third COVID-19 shot to healthy elementary-age kids.

More than 8,000 children have developed MIS-C since the start the pandemic, with kids ages 5 to 11 most commonly affected at 46% of reported cases, according to CDC data. Currently, only 29% of children ages 5 to 11 in the U.S. have complete their first Pfizer vaccination series, according to the CDC. Since the pandemic began, more than 4.8 million kids in the age group have caught Covid and more than 15,000 have been hospitalized, according CDC data. The overwhelming majority of reactions to the vaccine, 97%, were not serious, according to CDC data. The CDC has verified 20 cases of myocarditis, an inflammation of the heart, in kids ages 5 to 11 as of April following Pfizer vaccination.

U.S.[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]

Pfizer and its partner BioNTech make the only COVID-19 vaccine available for children of any age in the U.S.

The CDC must decide whether to formally recommend the booster for this age group.

U.S. regulators have authorized a COVID-19 vaccine booster for healthy children ages 5 to 11.

The Food and Drug Administration on Tuesday authorized a Pfizer booster dose for children ages 5 through 11 years old at least five months after they complete their two-dose primary series. Dr. Peter Marks, head of the FDA division responsible for vaccines, said data increasingly shows that the protection provided by two shots wanes off over time. The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks, Marks said. The FDA did not convene its committee of independent experts to discuss the data before authorizing the booster dose. New hospital admissions of people with Covid have also increased 8% over the past week, according to the CDC.

The drug giant’s purchase comes as good news for investors desperate for biotech M&A. It’s also a sensible addition to Pfizer’s portfolio.

Stocks rose in morning trading on Wall Street Tuesday as investors are tempted by lower prices a day after the S&P 500 hit its lowest level in more than a year.

The head of the World Health Organization has called on Pfizer to make its COVID-19 treatment more widely available in poorer countries.

The stocks making the biggest moves in premarket trading include Peloton, Novavax, Vroom, and more.

Shares are mixed in Asia with Chinese benchmarks pressing higher after a rally in technology companies helped reverse most of an early slide on Wall Street.

Novavax reported net income of $203 million in the first quarter, compared to a net loss of $222.7 million the same period last year.

The White House has warned that it does not have enough money to buy next generation Covid vaccines for all Americans ahead of a possible fall infection wave.

A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.

If symptoms return, FDA says there's "no evidence" taking more Paxlovid helps.

The FDA said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.

WASHINGTON (AP) — U.S.[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]

The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.

U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.

“​​I imagine this is what grapefruit juice mixed with soap would taste like.”

Prescriptions for Pfizer’s Covid-19 antiviral are skyrocketing, but it remains unclear how much the drug helps vaccinated patients — especially if they are at low risk of serious disease.

CEO Albert Bourla said Paxlovid prescriptions in the U.S. increased to 80,000 patients for the week ending April 22, up from 8,000 patients in late February.

Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid.

The biotech Arcturus has shown how new self-copying mRNA technology could get many people vaccinated quickly.

The following is a transcript of an interview with Dr. Paul Burton, chief medical officer at Moderna, that aired Sunday, May 1, 2022, on "Face the Nation."

The meetings are a sign that the vaccines are moving closer to a possible authorization.

The Food and Drug Administration has set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children.

Moderna is asking U.S. regulators to approve its COVID-19 vaccine for kids under 5 — the only group not yet eligible for vaccination.

Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation's youngest children.

Data show that a third dose can help boost kids' immunity. Some experts are skeptical that another shot is needed for younger kids.

Dr. Sandra Hughes prepares to administer a first dose of the Pfizer-BioNTech coronavirus vaccine (COVID-19) to Elise Langevina, 6, in Storrs, Connecticut, U.S., November 3, 2021. Pfizer on Tuesday asked the Food and Drug Administration to authorize a third dose of its Covid vaccine for children ages 5- to 11-years-old. The application comes after Pfizer released clinical trial data earlier this month showing that blood samples from 30 kids in the age group had a 36-fold increase in antibody levels against the omicron variant compared to two doses of the vaccine. This is breaking news. Please check back for updates.

COVID-19 patients have two treatment options that can be taken at home.

The White House has announced plans to let thousands of participating pharmacies directly order highly effective COVID-19 treatments like Paxlovid antiviral pills.

The following is a transcript of an interview with Dr. Scott Gottlieb that aired Sunday, April 24, 2022, on "Face the Nation."

COVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster.

Moderna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant.

The jab, seen as an alternative for people who are vaccine-hesitant, is widely available in the EU but still not cleared for use in the UK.

THE FOOD and Drug Administration and the Centers for Disease Control and Prevention recently authorized a second booster shot of the Pfizer/BioNTech and Moderna COVID-19 vaccines for those age 50

Pfizer tested the kid booster while Omicron was surging this winter.

Citing a "robust response" of antibodies against Omicron in their vaccine trials, the companies said they were planning to submit a request "in the coming days."

Pfizer wants to expand its COVID-19 booster shots to healthy 5- to 11-year-olds.

Germany’s health ministry says the country may have to discard 3 million doses of expired COVID-19 vaccine by the end of June.

A federal appeals court has upheld President Joe Biden’s requirement that all federal employees be vaccinated against COVID-19.

The FDA's top vaccine regulator Dr. Peter Marks said shortly after the decision that another round of boosters will likely be needed in the fall.

BA.2 makes up a growing a proportion of variants in the U.S., but new infections are still falling at the moment.

Do I need a 2nd booster shot? CDC director says omicron infection may act as 'natural booster'.

Even among the highest risk group, teenage boys, the risk of cardiac conditions was higher after Covid infection than Pfizer or Moderna vaccination.

Eligible individuals can either schedule appointments online or walk into pharmacies for same-day jabs.

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.

Democrats are trying to pass more COVID-19 funding after Republicans demanded it be cut out of a larger spending bill.

Both Pfizer and Moderna’s second COVID-19 vaccine booster were approved on Tuesday by...

Americans 50 and older can get a second COVID-19 booster if it’s been at least four months since their last vaccination, a chance at extra protection for the most vulnerable in case the coronavirus re[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]

After a stellar run in adult and teen trials, the vaccines are now trying to contend with Omicron, and the numbers show it.

A federal judge in Texas is barring the Navy from taking action for now against sailors who've objected to being vaccinated against COVID-19 on religious grounds.

The FDA is greatly expanding access to a fourth Covid shot. The supporting evidence is thin, but many people might want to get one.

On March 29, the FDA authorized another COVID-19 booster for people age 50 and older.

U.S. regulators authorized a fourth shot of the Pfizer or Moderna vaccines for people 50 and older at least four months after their previous booster.

U.S. regulators authorized a fourth shot of the Pfizer or Moderna vaccines for people 50 and older at least four months after their previous booster.

Americans age 50 and older can get a second COVID-19 booster if it’s been at least four months since their last vaccination.

The FDA made the decision comes without consulting its committee of independent vaccine experts.

The European Union's drug regulator says it has begun an accelerated review process for an experimental coronavirus vaccine booster made by the Spanish company Hipra.

Pharmaceutical executives have expressed conflicting stances on whether additional shots past the initial booster are necessary.

In "Moonshot," Pfizer’s chief executive Albert Bourla presents his account of a remarkable scientific advance achieved under extraordinary pressure.

"You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them," CEO Stephane Bancel told CNBC.

Moderna says it will ask regulators to authorize its COVID-19 vaccine for children under 6 but several hurdles need to be cleared before the shots could become available.

Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters under 6.

Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers.

Drugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

The U.N.-backed Medicines Patent Pool says that nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill.

Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors.

The European Medicines Agency said it has authorized Moderna’s coronavirus vaccine for children aged six to 11, in addition to recommending booster shots of Pfizer’s vaccine for those aged 12 and over.

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets.

U.S. health officials say some people getting Pfizer or Moderna COVID-19 vaccines should consider waiting up to eight weeks between the first and second doses.

The latest question into the KSAT Trust Index has to do with the COVID-19 vaccines that have now been fully approved by the U.S. Food and Drug Administration, which include the Pfizer and Moderna shots.

COVID-19 vaccines during pregnancy may protect babies after they're born and lead to fewer hospitalized infants.

A free COVID-19 rapid testing and vaccine clinic is opening Sunday morning on the city’s West Side.

U.S. regulators have put the brakes on their push to speed Pfizer’s COVID-19 vaccine to children under 5.

The Air Force has became the second military service to approve religious exemptions to the mandatory COVID-19 vaccine, granting requests from nine airmen to avoid the shots.

Ugandan authorities are seeking to legally mandate vaccines in draft legislation aimed at boosting the East African country's drive to inoculate more people against COVID-19.

Africa’s top health official is launching a campaign to enlist young people to encourage vaccinations, as just 11.3% of the continent’s 1.3 billion people are vaccinated against COVID-19.

COVID-19 vaccines still are saving untold lives, but omicron's easy spread has many wondering if they will need boosters every few months or even a new kind of shot altogether.

COVID-19 vaccines for kids under 5 may be available in the U.S. as early as March, but there are several hurdles still to clear.

Pfizer is asking U.S. regulators to authorize extra-low doses of its COVID-19 vaccine for children under 5.

U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old.

The World Health Organization says overuse of gloves and “moon suits” and the use of billions of masks and vaccination syringes to help prevent the spread of the coronavirus have spurred a huge glut of health care waste worldwide.

Thai health authorities have approved new guidelines outlining the parameters for declaring the coronavirus pandemic an endemic disease.

Guadalupe County will be hosting a free COVID-19 shot clinic in partnership with New Braunfels ISD and the Texas Department of State Health Services.

Texas Biomedical Research Institute is researching and developing variant-specific treatments to help in the fight against COVID-19.

Pfizer and BioNTech have begun studying a COVID-19 vaccine tweaked to match to the omicron variant in healthy adults.

A U.S. judge in Texas has issued a nationwide injunction barring the federal government from enforcing President Joe Biden’s requirement that federal workers without qualifying medical or religious exemptions be vaccinated for COVID-19.

Three new U.S. studies offer more evidence that the COVID-19 vaccines are standing up to the omicron variant, at least among people who have gotten booster shots.

German news agency dpa has reported that police are investigating thousands of cases of suspected forgery of coronavirus vaccine certificates.

The pharmaceutical giant GlaxoSmithKline says it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit.

Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.

South Korea has received its first supply of Pfizer’s antiviral COVID-19 pills to treat patients with mild or moderate symptoms.

Some immunocompromised people in San Antonio will be eligible to receive a fourth dose of the COVID-19 vaccine this month.